Biomapas is a pan-European pharmaceutical services provider rooted in the Baltics, offering worldwide Pharmacovigilance and Medical Information services along with specialized Clinical Development and Regulatory Affairs capabilities. The company combines global standards with local expertise, technology-driven efficiencies, and senior-level partnership to support clients effectively throughout the drug development process.

Founded in 2011, Biomapas provides reliable support for all phases of clinical trials, from patient recruitment to result delivery, ensuring efficient clinical research operations. It also offers flexible pharmacovigilance services to maintain product safety and compliance, alongside expert regulatory affairs assistance to navigate complex regulatory challenges confidently.

Beyond clinical and regulatory support, Biomapas delivers clear, accurate medical information tailored for global audiences around the clock, enhancing communication and understanding. Their quality assurance services include export audits designed to identify gaps and provide actionable solutions, reinforcing high standards.

Biomapas operates extensively across Central and Eastern Europe, Nordic, CIS, MENA, and LATAM regions, serving biopharmaceutical, medical device, cosmetics, and food supplement companies. Their in-house expertise and hands-on approach enable them to offer tailored solutions, efficiently addressing complex challenges from early development to commercial success.